The market size of pharmaceutical processing seals is estimated at USD 2.1 billion in 2021 and is projected to reach USD 3.3 billion by 2026, at a CAGR of 10.0% between 2021 and 2026. The growth of pharmaceutical processing seals market is attributed to the increased demand for pharmaceutical manufacturing equipment due to the growing healthcare industry and increasing consumption of pharmaceutical drugs. In addition, the expansion of healthcare industry in APAC due to favorable trade policies proposed by the government of countries in this region is expected to drive the pharmaceutical processing seals market.
Seals are an important part of pharmaceutical equipment and are used for various applications under pharmaceutical industry, such as to prevent contamination and leakage, and to handle friction and abrasion. The properties present in pharmaceutical processing seals such as excellent chemical resistance and stability at extreme temperatures and pressure conditions enable them to be used in different applications. These properties of pharmaceutical processing seals are expected to drive the demand during the forecast period.
The demand for pharmaceutical processing seals is mainly catered to by global players manufacturing these equipment’s for various end-use applications. The key players in the pharmaceutical processing seals market include Trelleborg AB (Sweden), Freudenberg Group (Germany), Flowserve Corporation (US), James Walker (UK), Parker Hannifin Corporation (US), Saint-Gobain S.A. (France), Garlock (US), John Crane (US), IDEX Corporation (US), and Morgan Advanced Materials Plc (UK).
